Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Hengameh Firouzmand, Mehrnosh Sahranavard, Ali Badiee, Ali Khamesipour, Seyedeh Hoda Alavizadeh, Afshin Samiei, Dina Soroush, Masoumeh Tavassoti Kheiri, Fereidoun Mahboudi & Mahmoud Reza Jaafari. (2018) The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model. Immunopharmacology and Immunotoxicology 40:1, pages 72-82.
Read now
Read now
Yao Ma, Huai-Jie An, Xiao-Qi Wei, Qing Xu, Yun-Zhou Yu & Zhi-Wei Sun. (2013) Enhanced potency of replicon vaccine using one vector to simultaneously co-express antigen and interleukin-4 molecular adjuvant. Human Vaccines & Immunotherapeutics 9:2, pages 242-249.
Read now
Read now
Douglas W Leaman. (2008) Recent progress in oligonucleotide therapeutics: antisense to aptamers. Expert Opinion on Drug Discovery 3:9, pages 997-1009.
Read now
Read now
Debbie Higgins, Jason D Marshall, Paula Traquina, Gary Van Nest & Brian D Livingston. (2007) Immunostimulatory DNA as a vaccine adjuvant. Expert Review of Vaccines 6:5, pages 747-759.
Read now
Read now
Dennis M. Klinman. (2006) Adjuvant Activity of CpG Oligodeoxynucleotides. International Reviews of Immunology 25:3-4, pages 135-154.
Read now
Read now
Sylvia Cohen-Kaminsky & Florence Jambou. (2005) Prospects for a T-cell receptor vaccination against myasthenia gravis. Expert Review of Vaccines 4:4, pages 473-492.
Read now
Read now
Szilvia Mosolits, Bo Nilsson & Håkan Mellstedt. (2005) Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Review of Vaccines 4:3, pages 329-350.
Read now
Read now
Joel R Haynes. (2004) Particle-mediated DNA vaccine delivery to the skin. Expert Opinion on Biological Therapy 4:6, pages 889-900.
Read now
Read now
Articles from other publishers (83)
Nathalie Garçon & Martin Friede. 2023. Plotkin's Vaccines. Plotkin's Vaccines
77
90.e4
.
David J Dowling & Ofer Levy. (2022) A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations. Clinical Infectious Diseases 75:Supplement_1, pages S30-S36.
Crossref
Crossref
Karlijn van Loon, Elisabeth J. M. Huijbers, Jan David de Haan & Arjan W. Griffioen. (2022) Cancer Vaccination against Extracellular Vimentin Efficiently Adjuvanted with Montanide ISA 720/CpG. Cancers 14:11, pages 2593.
Crossref
Crossref
Bassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner & Michael J. McCluskie. 2022. Vaccine Design. Vaccine Design
179
231
.
Yucheol Cheong, Minjin Kim, Jina Ahn, Hana Oh, Jongkwan Lim, Wonil Chae, Seung Won Yang, Min Seok Kim, Ji Eun Yu, Sanguine Byun, Yo Han Jang & Baik Lin Seong. (2021) Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant. Frontiers in Immunology 12.
Crossref
Crossref
Zamaneh Hajikhezri, Farzin Roohvand, Monireh Maleki, Shohreh Shahmahmoodi, Ali Akbar Amirzargar, Abolfazl Keshavarz, Negar Seyed, Mohammad Farahmand & Katayoun Samimi-Rad. (2021) HCV Core/NS3 Protein Immunization with “N-Terminal Heat Shock gp96 Protein (rNT (gp96))” Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice. Vaccines 9:3, pages 215.
Crossref
Crossref
Yun Hu, Daniel Smith, Evan Frazier, Zongmin Zhao & Chenming Zhang. (2021) Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine. Molecular Pharmaceutics 18:3, pages 1293-1304.
Crossref
Crossref
Neslihan Kayraklioglu, Begum Horuluoglu & Dennis M. Klinman. 2021. DNA Vaccines. DNA Vaccines
51
85
.
Hae-Ji Kang, Ki-Back Chu, Min-Ju Kim, Hyunwoo Park, Hui Jin, Su-Hwa Lee, Eun-Kyung Moon & Fu-Shi Quan. (2020) Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations. Pharmaceutics 12:10, pages 989.
Crossref
Crossref
Alba Martín-Martín, Lydia Tejedor, Carolina Tafalla & Patricia Díaz-Rosales. (2020) Potential of the Escherichia coli LT(R192G/L211A) toxoid as a mucosal adjuvant for rainbow trout (Oncorhynchus mykiss). Fish & Shellfish Immunology 105, pages 310-318.
Crossref
Crossref
Xiang Sun, Peng Jin, Qin Liu, Qiyao Wang, Yuanxing Zhang & Xiaohong Liu. (2020) A CpG-riched plasmid as vaccine adjuvant reduce antigen dose of an inactivated Vibrio anguillarum vaccine in turbot (Scophthalmus maximus L.). Fish & Shellfish Immunology 98, pages 312-317.
Crossref
Crossref
Etsuro Nanishi, David J. Dowling & Ofer Levy. (2020) Toward precision adjuvants: optimizing science and safety. Current Opinion in Pediatrics 32:1, pages 125-138.
Crossref
Crossref
Chunwei Ong, Bong Geun Cha & Jaeyun Kim. (2019) Mesoporous Silica Nanoparticles Doped with Gold Nanoparticles for Combined Cancer Immunotherapy and Photothermal Therapy. ACS Applied Bio Materials 2:8, pages 3630-3638.
Crossref
Crossref
Eun-Ju Ko, Youri Lee, Young-Tae Lee, Yu-Jin Kim, Ki-Hye Kim & Sang-Moo Kang. (2018) MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine. Antiviral Research 156, pages 107-115.
Crossref
Crossref
Hui Liu, Zhenghu Jia, Chengmao Yang, Mei Song, Zhe Jing, Yapu Zhao, Zhenzhou Wu, Liqing Zhao, Dongsheng Wei, Zhinan Yin & Zhangyong Hong. (2018) Aluminum hydroxide colloid vaccine encapsulated in yeast shells with enhanced humoral and cellular immune responses. Biomaterials 167, pages 32-43.
Crossref
Crossref
Dongdong Qiao, Lixin Liu, Yi Chen, Chenbao Xue, Qiang Gao, Hai-Quan Mao, Kam W. Leong & Yongming Chen. (2018) Potency of a Scalable Nanoparticulate Subunit Vaccine. Nano Letters 18:5, pages 3007-3016.
Crossref
Crossref
Kuang Tan, Ruizhen Li, Xiaotian Huang & Qiong Liu. (2018) Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants. Frontiers in Microbiology 9.
Crossref
Crossref
Peyman BakhshaeiMohammad Hossein KazemiMaryam GolaraSara AbdolmalekiRoya Khosravi-EghbalJalal KhoshnoodiMohammad Ali JudakiVahid SalimiMasoumeh DouraghiMahmood Jeddi-TehraniFazel Shokri. (2018)
Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of
Bordetella pertussis
in BALB/c Mice
. Journal of Interferon & Cytokine Research 38:4, pages 161-170.
Crossref
Crossref
Nathalie Garçon & Martin Friede. 2018. Plotkin's Vaccines. Plotkin's Vaccines
61
74.e4
.
Ian Kimber & Juan-Carlos Carrillo. (2016) Oral exposure to mineral oils: Is there an association with immune perturbation and autoimmunity?. Toxicology 344-346, pages 19-25.
Crossref
Crossref
CHAO-HENG YU, ZI-CHAO LUO, MENG LI, LIAN LU, ZHAN LI, XIAO-ZHE WU, YING-ZI FAN, HAI-LONG ZHANG, BAI-LING ZHOU, YANG WAN, KE MEN, YAO-MEI TIAN, SHUANG CHEN, FENG-JIAO YUAN, RONG XIANG & LI YANG. (2016) Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long-lasting and balanced immune responses. Molecular Medicine Reports 13:1, pages 915-924.
Crossref
Crossref
Yun-Zhou Yu, Yao Ma, Wen-Hui Xu, Shuang Wang & Zhi-Wei Sun. (2014) Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines. Medical Microbiology and Immunology 204:4, pages 481-491.
Crossref
Crossref
Milan Raska & Jaroslav Turanek. 2015. Mucosal Immunology. Mucosal Immunology
1307
1335
.
Faeze Eskandari, Ghazal Alipour Talesh, Maryam Parooie, Mahmoud Reza Jaafari, Ali Khamesipour, Zahra Saberi, Azam Abbasi & Ali Badiee. (2014) Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis. Experimental Parasitology 146, pages 78-86.
Crossref
Crossref
Ahmed A. Eltoukhy, Delai Chen, Omid Veiseh, Jeisa M. Pelet, Hao Yin, Yizhou Dong & Daniel G. Anderson. (2014) Nucleic acid-mediated intracellular protein delivery by lipid-like nanoparticles. Biomaterials 35:24, pages 6454-6461.
Crossref
Crossref
Rohan S. Ingrole, Wenqian Tao, Jatindra N. Tripathy & Harvinder S. Gill. (2014) Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen. Nano LIFE 04:02, pages 1450004.
Crossref
Crossref
Wenqian Tao, Katherine S Ziemer & Harvinder S Gill. (2014) Gold nanoparticle–M2e conjugate coformulated with CpG induces protective immunity against influenza A virus. Nanomedicine 9:2, pages 237-251.
Crossref
Crossref
Lilly Ganju & Divya Singh. 2014. Translational Research in Environmental and Occupational Stress. Translational Research in Environmental and Occupational Stress
117
134
.
Ana Rostaher Prélaud, Sebastian Fuchs, Karin Weber, Gerhard Winter, Conrad Coester & Ralf S. Mueller. (2013)
In vitro
effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs - a pilot study
. Veterinary Dermatology 24:5, pages 494-e117.
Crossref
Crossref
Lon Kendall. 2013. Making and Using Antibodies. Making and Using Antibodies
33
65
.
Yingjie Cheng, Zongyan Chen, Chuanfeng Li, Chun Meng, Run Wu & Guangqing Liu. (2013) Protective immune responses in rabbits induced by a suicidal DNA vaccine of the VP60 gene of rabbit hemorrhagic disease virus. Antiviral Research 97:3, pages 227-231.
Crossref
Crossref
Nathalie. Garçon, Stanley. Hem & Martin. Friede. 2013. Vaccines. Vaccines
58
70
.
Yun‐Zhou Yu, Na Li, Yao Ma, Shuang Wang, Wei‐Yuan Yu & Zhi‐Wei Sun. (2012)
Three types of human
C
p
G
motifs differentially modulate and augment immunogenicity of nonviral and viral replicon
DNA
vaccines as built‐in adjuvants
. European Journal of Immunology 43:1, pages 228-239.
Crossref
Crossref
Seyedeh Hoda Alavizadeh, Ali Badiee, Ali Khamesipour, Seyed Amir Jalali, Hengameh Firouzmand, Azam Abbasi & Mahmoud Reza Jaafari. (2012) The role of liposome–protamine–DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice. Experimental Parasitology 132:3, pages 313-319.
Crossref
Crossref
Kristin J. Flores, Michael Craig, Adam Wanekaya, Lifeng Dong, Kartik Ghosh, Joshua J. Smith & Robert K. DeLong. (2012) Tipping the Proteome with Gene-Based Vaccines: Weighing in on the Role of Nanomaterials. Journal of Nanotechnology 2012, pages 1-9.
Crossref
Crossref
Mark A. Tomai & John P. Vasilakos. 2012. Innovation in Vaccinology. Innovation in Vaccinology
205
228
.
Masaki Yamamoto, Takashi Sato, Joel Beren, Daniela Verthelyi & Dennis M. Klinman. (2011) The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides. Biomaterials 32:18, pages 4238-4242.
Crossref
Crossref
Jason R. Clark, Kathryn Bartley, Catherine D. Jepson, Vicki Craik & John B. March. (2011) Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B. FEMS Immunology & Medical Microbiology 61:2, pages 197-204.
Crossref
Crossref
Ang Li, Lili Qin, Wenrui Wang, Rongrong Zhu, Yongchun Yu, Hui Liu & Shilong Wang. (2011) The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response. Biomaterials 32:2, pages 469-477.
Crossref
Crossref
Yun-Zhou Yu, Wen-Bin Wang, Na Li, Shuang Wang, Wei-Yuan Yu & Zhi-Wei Sun. (2010) Enhanced potency of individual and bivalent DNA replicon vaccines or conventional DNA vaccines by formulation with aluminum phosphate. Biologicals 38:6, pages 658-663.
Crossref
Crossref
Wilbur H. ChenSubhendu Basu, Apurba K. Bhattacharjee & Alan S. Cross. (2009) Enhanced antibody responses to a detoxified lipopolysaccharide-group B meningococcal outer membrane protein vaccine are due to synergistic engagement of Toll-like receptors. Innate Immunity 16:5, pages 322-332.
Crossref
Crossref
Tetsuya Yoshida, Ryoko Yoshida, Bruce Yong Ma, Sebastian Mikolajczak, David J. Kelvin & Atsuo Ochi. (2010) A novel mitogen fusion protein against CD40+ cells with potent vaccine adjuvant properties. Vaccine 28:21, pages 3688-3695.
Crossref
Crossref
Ian Kimber & Rebecca J. Dearman. (2010) An assessment of the ability of phthalates to influence immune and allergic responses. Toxicology 271:3, pages 73-82.
Crossref
Crossref
Han-Ning Huang, Tsung-Lin Li, Yi-Lin Chan, Chien-Lung Chen & Chang-Jer Wu. (2009) Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus. Biomaterials 30:30, pages 6017-6025.
Crossref
Crossref
KyungDong Bae, JunYoul Choi, YangSuk Jang, SangJeom Ahn & ByungKi Hur. (2009) Innovative vaccine production technologies: The evolution and value of vaccine production technologies. Archives of Pharmacal Research 32:4, pages 465-480.
Crossref
Crossref
Dennis M. Klinman, Sven Klaschik, Takashi Sato & Debbie Tross. (2009) CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Advanced Drug Delivery Reviews 61:3, pages 248-255.
Crossref
Crossref
Sameer Sharma, T.K.S. Mukkur, Heather A.E. Benson & Yan Chen. (2009) Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems. Journal of Pharmaceutical Sciences 98:3, pages 812-843.
Crossref
Crossref
Mary Christopher & Jonathan Wong. (2008) Broad-Spectrum Drugs Against Viral Agents. International Journal of Molecular Sciences 9:9, pages 1561-1594.
Crossref
Crossref
Weihsu Chen, Weili Yan & Leaf Huang. (2007) A simple but effective cancer vaccine consisting of an antigen and a cationic lipid. Cancer Immunology, Immunotherapy 57:4, pages 517-530.
Crossref
Crossref
Klaus Heeg, Alexander Dalpke, Mirjam Peter & Stefan Zimmermann. (2008) Structural requirements for uptake and recognition of CpG oligonucleotides. International Journal of Medical Microbiology 298:1-2, pages 33-38.
Crossref
Crossref
Frederick R. Vogel & Stanley L. Hem. 2008. Vaccines. Vaccines
59
71
.
Thomas C. Heineman. 2009. Human Herpesviruses. Human Herpesviruses
1274
1291
.
Alla Amcheslavsky & Zvi Bar-Shavit. (2007) Toll-Like Receptor 9 Ligand Blocks Osteoclast Differentiation Through Induction of Phosphatase. Journal of Bone and Mineral Research 22:8, pages 1301-1310.
Crossref
Crossref
Guangyu He, Amritraj Patra, Karsten Siegmund, Mirjam Peter, Klaus Heeg, Alexander Dalpke & Clemens Richert. (2007) Immunostimulatory CpG Oligonucleotides Form Defined Three-Dimensional Structures: Results from an NMR Study. ChemMedChem 2:4, pages 549-560.
Crossref
Crossref
Susantha Gomis, Lorne Babiuk, Brenda Allan, Philip Willson, Edwin Waters, Rolf Hecker & Andrew Potter. (2007) Protection of Chickens Against a Lethal Challenge of Escherichia coli by a Vaccine Containing CpG Oligodeoxynucleotides as an Adjuvant. Avian Diseases 51:1, pages 78-83.
Crossref
Crossref
Lon Kendall. 2006. Making and Using Antibodies. Making and Using Antibodies
41
72
.
J. N. Sidhapuriwala, S. P. Sivalingam, J. Lu & S. M. Moochhala. (2006) Immunomodulation of Japanese Encephalitis Vaccine Through CpG Oligodeoxynucleotides in Mice. Scandinavian Journal of Immunology 64:4, pages 370-375.
Crossref
Crossref
Rong Liang, Jan V. van den Hurk, Lorne A. Babiuk & Sylvia van Drunen Littel-van den Hurk. (2006) Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. Journal of General Virology 87:10, pages 2971-2982.
Crossref
Crossref
E. A. INNES & A. N. VERMEULEN. (2007)
Vaccination as a control strategy against the coccidial parasites
Eimeria
,
Toxoplasma
and
Neospora
. Parasitology 133:S2, pages S145-S168.
Crossref
Crossref
Hso-Chi Chaung. (2006) CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy. International Immunopharmacology 6:10, pages 1586-1596.
Crossref
Crossref
Karen Zaks, Michael Jordan, Amanda Guth, Karen Sellins, Ross Kedl, Angelo Izzo, Catharine Bosio & Steven Dow. (2006) Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes. The Journal of Immunology 176:12, pages 7335-7345.
Crossref
Crossref
Louise J. McHeyzer‐WilliamsLaurent P. MalherbeMichael G. McHeyzer‐Williams. (2006) Checkpoints in memory B‐cell evolution. Immunological Reviews 211:1, pages 255-268.
Crossref
Crossref
Aviva Joseph, Noga Itskovitz-Cooper, Sarit Samira, Orli Flasterstein, Hagit Eliyahu, Dmitri Simberg, Itzik Goldwaser, Yechezkel Barenholz & Eli Kedar. (2006) A new intranasal influenza vaccine based on a novel polycationic lipid—ceramide carbamoyl-spermine (CCS). Vaccine 24:18, pages 3990-4006.
Crossref
Crossref
Alla Amcheslavsky & Zvi Bar-Shavit. (2006) Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. Journal of Cellular Physiology 207:1, pages 244-250.
Crossref
Crossref
Daiko Wakita, Kenji Chamoto, Yue Zhang, Yoshinori Narita, Daisuke Noguchi, Hideaki Ohnishi, Takeshi Iguchi, Tomoaki Sakai, Hiroaki Ikeda & Takashi Nishimura. (2006) An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen. International Immunology 18:3, pages 425-434.
Crossref
Crossref
Sylvia van Drunen Littel-van den Hurk. (2006) Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Veterinary Microbiology 113:3-4, pages 275-282.
Crossref
Crossref
Min Yu & Olivera J. Finn. (2005) DNA vaccines for cancer too. Cancer Immunology, Immunotherapy 55:2, pages 119-130.
Crossref
Crossref
Ge Jiang, Sangeeta B. Joshi, Laura J. Peek, Duane T. Brandau, Juan Huang, Matthew S. Ferriter, Wendy D. Woodley, Brandi M. Ford, Kevin D. Mar, John A. Mikszta, C.Robin Hwang, Robert Ulrich, Noel G. Harvey, C.Russell Middaugh & Vincent J. Sullivan. (2006) Anthrax vaccine powder formulations for nasal mucosal delivery. Journal of Pharmaceutical Sciences 95:1, pages 80-96.
Crossref
Crossref
Jacob Glenting & Stephen Wessels. (2005) Ensuring safety of DNA vaccines. Microbial Cell Factories 4:1.
Crossref
Crossref
Tanawatt Kootiratrakarn, Taku Fujimura, Kunio Sano, Ryuhei Okuyama, Setsuya Aiba, Hachiro Tagami & Tadashi Terui. (2005) Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model. European Journal of Immunology 35:11, pages 3277-3286.
Crossref
Crossref
Alla Amcheslavsky, Hiroaki Hemmi, Shizuo Akira & Zvi Bar-Shavit. (2005) Differential Contribution of Osteoclast- and Osteoblast-Lineage Cells to CpG-Oligodeoxynucleotide (CpG-ODN) Modulation of Osteoclastogenesis. Journal of Bone and Mineral Research 20:9, pages 1692-1699.
Crossref
Crossref
S. Mosolits, G. Ullenhag & H. Mellstedt. (2005) Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results. Annals of Oncology 16:6, pages 847-862.
Crossref
Crossref
Yukui Li, Ekambar R. Kandimalla, Dong Yu & Sudhir Agrawal. (2005) Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice. International Immunopharmacology 5:6, pages 981-991.
Crossref
Crossref
Hansi J. Dean, Joel Haynes & Connie Schmaljohn. (2005) The role of particle-mediated DNA vaccines in biodefense preparedness. Advanced Drug Delivery Reviews 57:9, pages 1315-1342.
Crossref
Crossref
Asmi Citra Malina A.R. Tassakka & Masahiro Sakai. (2005) Current research on the immunostimulatory effects of CpG oligodeoxynucleotides in fish. Aquaculture 246:1-4, pages 25-36.
Crossref
Crossref
Fabrice Cognasse, Sophie Acquart, Lydie Beniguel, Odile Sabido, Patricia Chavarin, Christian Genin & Olivier Garraud. (2005) Differential production of immunoglobulin classes and subclasses by mucosal-type human B-lymphocytes exposed in vitro to CpG oligodeoxynucleotides. Clinical Chemistry and Laboratory Medicine (CCLM) 43:1.
Crossref
Crossref
Peter Silvera, Jay R. Savary, Virginia Livingston, Jessica White, Kelledy H. Manson, Michael H. Wyand, Peter L. Salk, Ronald B. Moss & Mark G. Lewis. (2004) Vaccination with gp120-depleted HIV-1 plus immunostimulatory CpG oligodeoxynucleotides in incomplete Freund's adjuvant stimulates cellular and humoral immunity in rhesus macaques. Vaccine 23:6, pages 827-839.
Crossref
Crossref
Fumihiko Takeshita, Koichi Suzuki, Shin Sasaki, Norihisa Ishii, Dennis M. Klinman & Ken J. Ishii. (2004) Transcriptional Regulation of the Human TLR9 Gene. The Journal of Immunology 173:4, pages 2552-2561.
Crossref
Crossref
Dennis M. Klinman, Debra Currie, Ihsan Gursel & Daniela Verthelyi. (2004) Use of CpG oligodeoxynucleotides as immune adjuvants. Immunological Reviews 199:1, pages 201-216.
Crossref
Crossref
Hong Yu, Lorne A. Babiuk & Sylvia van Drunen Littel-van den Hurk. (2004) Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3. Journal of General Virology 85:6, pages 1533-1543.
Crossref
Crossref
Wu-Shiun Hou & Luk Van Parijs. (2004) A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nature Immunology 5:6, pages 583-589.
Crossref
Crossref
Dennis M. Klinman. (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nature Reviews Immunology 4:4, pages 249-259.
Crossref
Crossref
Mark Jenkins, Carolyn Parker, Wenbin Tuo, Bryan Vinyard & J. P. Dubey. (2004) Inclusion of CpG Adjuvant with Plasmid DNA Coding for NcGRA7 Improves Protection against Congenital Neosporosis. Infection and Immunity 72:3, pages 1817-1819.
Crossref
Crossref